SillaJen
Founded in 2003 and headquartered in South Korea, SillaJen is a biotechnology company that is focused on the development and commercialization of oncolytic immunotherapy products using the SOLVE platform.
Last updated on
About SillaJen
Founded
2003Estimated Revenue
$0-$1MEmployees
51-250Category
Industry
BiotechnologyLocation
City
BusanState
BusanCountry
South KoreaSillaJen
Find your buyer within SillaJen
Tech Stack (24)
